SGMO · long Sangamo Therapeutics INC
Sangamo Therapeutics, an OTC-listed genomic medicine pioneer, spent 25 years and billions developing its platform.
OTC
Sangamo Therapeutics, INC
SGMO
2 stories
$29M Market cap · 2026-11-03
Get SGMO news in Claude, ChatGPT or your own code. See plans
SGMO · long 
Sangamo Bankruptcy (SGMOQ)
Sangamo Therapeutics’ Chapter 11 asset sales leave common equity tied to $100 million in PTC Fabry therapy approval milestones and a…
